Skip to content

Establishment and application of a risk stratification proposal of IgA nephropathy: a case records based study

Establishment and application of a risk stratification proposal of IgA nephropathy.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ROC-16009544
Enrollment
Unknown
Registered
2016-10-21
Start date
2016-11-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IgA nephropathy

Interventions

Case series:Nil

Sponsors

Ruijin Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. aged 18 years old and more; 2. diagnosed with primary IgA nephropathy by renal biopsy; 3. follow up duration more than 6 months; 4. estimated glomerular filtration rate with EPI equation(eGFR-EPI)=15ml/min.

Exclusion criteria

Exclusion criteria: 1. diagnosed with systemic diseases, including systemic lupus erythematosus (SLE),Henoch-Schonlein purpura (HSP), chronic hepatic disease, etc.; 2. complicated with severe heart disease (NYHA classification III-IV); 3. diabetes patients with poor control; 4. patients with severe hepatic disease (GPT or GOT continuously above twice of the normal range) or with detectable HBV-DNA.

Design outcomes

Primary

MeasureTime frame
end stage renal disease;

Secondary

MeasureTime frame
50% decline of eGFR;double of baseline serum creatinine;

Countries

China

Contacts

Public ContactXie Jingyuan

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

nephroxie@163.com+86 13761056656

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026